Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 2, 2007

BAC and GE Healthcare Collaborate

  • BAC and GE Healthcare will together develop and market affinity chromatography media for the purification of therapeutic recombinant Factor VIII.

    BAC will provide its CaptureSelect® affinity ligands for  process-scale purification of FVIII for the prevention and treatment of bleeding in patients with haemophilia A.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »